ArticleAnnals of surgical oncology2026

EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Progression.

An Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.